Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX4 anticorps (AA 63-91)

L’anticorps Lapin Polyclonal anti-SSX4 a été validé pour WB. Il convient pour détecter SSX4 dans des échantillons de Humain.
N° du produit ABIN657137

Aperçu rapide pour SSX4 anticorps (AA 63-91) (ABIN657137)

Antigène

Voir toutes SSX4 Anticorps
SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

Reactivité

  • 32
  • 1
Humain

Hôte

  • 28
  • 4
Lapin

Clonalité

  • 30
  • 2
Polyclonal

Conjugué

  • 15
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SSX4 est non-conjugé

Application

  • 24
  • 19
  • 2
  • 2
  • 1
Western Blotting (WB)

Clone

RB32991
  • Épitope

    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 63-91

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This SSX4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 63-91 amino acids from the Central region of human SSX4.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Antigène

    SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))

    Autre désignation

    SSX4

    Sujet

    The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4B, represents the more centromeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.

    Poids moléculaire

    21858

    NCBI Accession

    NP_001030004, NP_001035702, NP_005627, NP_783856

    UniProt

    O60224
Vous êtes ici:
Chat with us!